Rebsdorf Medical ApS: Financial statements 2024
CVR: 42080578
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Rebsdorf Medical ApS (CVR 42080578) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,209,669 and a net result of DKK 1,864,374 compared with DKK 126,817 the year before. Equity in the 2024 report amounted to DKK 40,000. The solvency ratio was 100%.
- Gross Profit
- DKK 2,209,669
- Profit/Loss
- DKK 1,864,374
- Equity
- DKK 40,000
- Total Assets
- DKK 40,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2.2M | 1.9M | 40K | 0 |
| 2023 | - | - | 127K | 40K | - |
| 2022 | - | - | -48K | 40K | - |
| 2021 | -1.3M | 6K | 5K | 40K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Rebsdorf Medical ApS has published its annual report for 2023. The net result was DKK 126,817.
About Rebsdorf Medical ApS
Rebsdorf Medical ApS is a Danish company of the type Anpartsselskab based in Fredericia, founded in 2021. The company is under bankruptcy. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company is owned by Rebsdorf Global Holding ApS. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK 2,209,669 and a net result of DKK 1,864,374 compared with DKK 126,817 the year before. Equity in the 2024 report amounted to DKK 40,000.
